Pharma

Jan 8 2018

Cipla, Aurobindo Pharma acquire products divested by Teva in US #pharmaceutical #manufacturers #association

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …

Nov 30 2017

Cipla, Aurobindo Pharma acquire products divested by Teva in US #noel #pharma

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …

Aug 15 2017

Cipla, Aurobindo Pharma acquire products divested by Teva in US #online #pharma

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …

Jul 9 2017

Cipla, Aurobindo Pharma acquire products divested by Teva in US #new #pharmaceutical #companies

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …

Feb 12 2017

Cipla, Aurobindo Pharma acquire products divested by Teva in US #sciele #pharma

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …

Jan 30 2017

Cipla, Aurobindo Pharma acquire products divested by Teva in US #pharma #manufacturing

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …

Dec 9 2016

Cipla, Aurobindo Pharma acquire products divested by Teva in US #top #pharma #companies #2013

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …

Nov 21 2016

Cipla, Aurobindo Pharma acquire products divested by Teva in US #purdue #pharmaceutical

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …

Nov 3 2016

Cipla, Aurobindo Pharma acquire products divested by Teva in US #pharmaceutical #research #jobs

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …

Oct 27 2016

Cipla, Aurobindo Pharma acquire products divested by Teva in US #pharma #online

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …

Oct 5 2016

Cipla, Aurobindo Pharma acquire products divested by Teva in US #pharma #etf

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …